The future of MS in cancer research looks promising with ongoing advancements:
Personalized Medicine: MS could play a key role in personalized medicine by enabling the identification of patient-specific biomarkers and tailoring treatments accordingly. Early Detection: Improving the sensitivity of MS could lead to the development of non-invasive tests for early cancer detection. Real-Time Analysis: Advancements in real-time MS analysis could allow for immediate monitoring of cancer progression and treatment response.
